Paridiprubart (NI-0101) is a humanised anti-TLR4 monoclonal antibody. Paridiprubar inhibits the production of pro-inflammatory cytokines by monocytes from rheumatoid arthritis specimen induced by rheumatoid arthritis synovial fluid (RASF). Paridiprubart can be used for the study of rheumatoid arthritis[1].
Molecular Weight:
(145.16 kDa)
Purity:
95
CAS Number:
[2641646-59-3]
Target:
Toll-like Receptor (TLR)
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted